Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
DTIL
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
☁️ News word cloud
Top words across the last 50 articles for this ticker.
precision
biosciences
nasdaq
trading
estimates
revenue
market
last
price
loss
revenues
2022
high
analysts
rating
reports
fourth
expected
after
hold
52w high -21.1%
DTIL
Precision BioSciences, Inc. Common Stock
StonvexStonvexStonvexStonvex